These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32793396)

  • 21. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
    Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ
    J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FBXO22 inhibits proliferation and metastasis of cervical cancer cells by mediating ubiquitination-dependent degradation of GAK.
    Li S; Shi L; Wang Y; Zhang L; Chu S; Li M; Bai J; Zhu W
    Exp Cell Res; 2023 Sep; 430(1):113719. PubMed ID: 37442264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth.
    Zhu XN; He P; Zhang L; Yang S; Zhang HL; Zhu D; Liu MD; Yu Y
    Cell Death Dis; 2019 Jun; 10(7):486. PubMed ID: 31217475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct Perception Mechanisms of BACH1 Quaternary Structure Degrons by Two F-box Proteins under Oxidative Stress.
    Cao S; Shi H; Garcia SF; Kito Y; Shi H; Goldberg HV; Ponce J; Ueberheide B; Lignitto L; Pagano M; Zheng N
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.
    Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H
    Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FBXO22 degrades nuclear PTEN to promote tumorigenesis.
    Ge MK; Zhang N; Xia L; Zhang C; Dong SS; Li ZM; Ji Y; Zheng MH; Sun J; Chen GQ; Shen SM
    Nat Commun; 2020 Apr; 11(1):1720. PubMed ID: 32249768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine.
    Dikopoltsev E; Foltyn VN; Zehl M; Jensen ON; Mori H; Radzishevsky I; Wolosker H
    J Biol Chem; 2014 Dec; 289(49):33904-15. PubMed ID: 25336657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2.
    Ma J; Wu Y; Cheng S; Yang W; Zhong L; Li Q; Fang L
    Dig Dis Sci; 2023 May; 68(5):1913-1922. PubMed ID: 36515852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage.
    De S; Holvey-Bates EG; Mahen K; Willard B; Stark GR
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34795058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer.
    Zhang Y; Li W; Guo S; Wu Z; Zhang L; Liu Y; Li X; Guo X; Cao J; Yang C; Wang Z
    Am J Pathol; 2023 Sep; 193(9):1248-1266. PubMed ID: 37301536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recruitment of FBXO22 for Targeted Degradation of NSD2.
    Nie DY; Tabor JR; Li J; Kutera M; St-Germain J; Hanley RP; Wolf E; Paulakonis E; Kenney TMG; Duan S; Shrestha S; Owens DDG; Pon A; Szewczyk M; Lamberto AJ; Menes M; Li F; Barsyte-Lovejoy D; Brown NG; Barsotti AM; Stamford AW; Collins JL; Wilson DJ; Raught B; Licht JD; James LI; Arrowsmith CH
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E3 ligase FBXO22 is not significant for spermatogenesis and male fertility in mice.
    Wu T; Jin X; Huang C; Yu X; Xu B; Gao W; Qiu X; Bao M; Zhao D; Feng G; Zheng B; Huang X
    Am J Transl Res; 2024; 16(5):1834-1844. PubMed ID: 38883371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recruitment of FBXO22 for targeted degradation of NSD2.
    Nie DY; Tabor JR; Li J; Kutera M; St-Germain J; Hanley RP; Wolf E; Paulakonis E; Kenney TMG; Duan S; Shrestha S; Owens DDG; Maitland MER; Pon A; Szewczyk M; Lamberto AJ; Menes M; Li F; Penn LZ; Barsyte-Lovejoy D; Brown NG; Barsotti AM; Stamford AW; Collins JL; Wilson DJ; Raught B; Licht JD; James LI; Arrowsmith CH
    Nat Chem Biol; 2024 Dec; 20(12):1597-1607. PubMed ID: 38965384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FBXO22, ubiquitination degradation of PHLPP1, ameliorates rotenone induced neurotoxicity by activating AKT pathway.
    Zheng X; Yu S; Xue Y; Yan F
    Toxicol Lett; 2021 Oct; 350():1-9. PubMed ID: 34182063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
    Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
    Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. F-box only protein 9 and its role in cancer.
    Hussain S; Dong J; Ma X; Li J; Chen S; Clement A; Liu H
    Mol Biol Rep; 2022 Feb; 49(2):1537-1544. PubMed ID: 35025031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of FBXL7 as a novel player in human cancers.
    Wang Y; Shen X; Gong L; Zhao Y; Xiong X
    Cell Death Discov; 2022 Jul; 8(1):342. PubMed ID: 35906197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FBXO22 is a potential therapeutic target for recurrent chondrosarcoma.
    Xin B; Chen H; Zhu Z; Guan Q; Bai G; Yang C; Zou W; Gao X; Li L; Liu T
    J Bone Oncol; 2024 Jun; 46():100605. PubMed ID: 38742151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The characteristics and roles of β-TrCP1/2 in carcinogenesis.
    Bi Y; Cui D; Xiong X; Zhao Y
    FEBS J; 2021 Jun; 288(11):3351-3374. PubMed ID: 33021036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LKB1 obliterates Snail stability and inhibits pancreatic cancer metastasis in response to metformin treatment.
    Song L; Guo J; Chang R; Peng X; Li J; Xu X; Zhan X; Zhan L
    Cancer Sci; 2018 May; 109(5):1382-1392. PubMed ID: 29601127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.